Endpoints News Launches Industry Sentiment Survey, But No Evidence Yet of a New Biopharma Sentiment Index
Endpoints News regularly discusses and surveys biopharma sentiment—John Carroll, the founding editor, conducts a twice-yearly sentiment survey, as highlighted in promotional material for a live event7.
As of October 2025, there is no direct public evidence in the search results indicating that Endpoints is building a new, dedicated Biopharma Sentiment Index beyond its existing editorial surveys and engagement with industry leaders7.
The Endpoints 100 survey actively polls biopharma executives for their outlook on FDA and HHS policy, US-China relations, AI, and financing, suggesting ongoing but editorial—not quantitative index—engagement with industry sentiment5.
Endpoints continues to be recognized for its coverage of biopharma trends, awards (such as the Endpoints 11), and events, but a formal 'Sentiment Index' has not been announced or described in the available results357.
Sources:
3. https://www.businesswire.com/news/home/20250919331146/en/Endpoints-News-Announces-the-2025-Winners-of-the-Endpoints-11-Awards-Highlighting-Biotechs-Most-Promising-Startups